MeOSuc-AAPV-AFC integrates a methoxysuccinyl-protected peptide sequence with a fluorogenic AFC group for monitoring enzymatic cleavage. Residue selection supports protease-recognition studies and kinetic profiling. Researchers assess fluorescence changes to characterize catalytic behavior. Uses include substrate-validation assays, enzyme-mechanism mapping, and biochemical method development.
CAT No: R2338
CAS No:125791-90-4
Synonyms/Alias:MeOSuc-AAPV-AFC;Meosuc-Ala-Ala-Pro-Val-7-Amino-4-Trifluoro-Methylcoumarin;FLFLPZJVJVKNIW-BYRWETQCSA-N;HY-P5374;DA-55339;CS-0882855;125791-90-4;methyl 4-((S)-1-((S)-1-((S)-2-((S)-3-methyl-1-oxo-1-(2-oxo-4-(trifluoromethyl)-2H-chromen-7-ylamino)butan-2-ylcarbamoyl)pyrrolidin-1-yl)-1-oxopropan-2-ylamino)-1-oxopropan-2-ylamino)-4-oxobutanoate;
2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
4. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.